SCHEMBL8770858

SCHEMBL8770858

O=C(O)c1ccc(C(=O)O)c(C(=O)Nc2ccc(C(=O)c3ccc(NC(=O)c4cc(C(=O)O)ccc4C(=O)O)cc3)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.58
▸ ALDH1A1 P00352 3/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.57
▸ GFER P55789 1/20 0.56
▸ RAB9A P51151 5/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ TDP1 Q9NUW8 2/20 0.53
▸ POLB P06746 2/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ LMNA P02545 1/20 0.52
▸ MAPT P10636 1/20 0.49
▸ HPSE Q9Y251 1/20 0.49
▸ MITF O75030 1/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ PKM P14618 1/20 0.46
▸ PRSS12 P56730 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14426507 0.95 ALDH1A1 (0.62) FFAR1ALDH1A1CYP1A2HPGDKDM4E
SCHEMBL10616433 0.88 ALDH1A1 (0.68) FFAR1ALDH1A1CYP1A2HPGDKDM4E
SCHEMBL8900345 0.86 KMT2A (0.59) FFAR1ALDH1A1CYP1A2HPGDKDM4E
SCHEMBL29233050 0.86 KMT2A (0.59) FFAR1ALDH1A1CYP1A2HPGDKDM4E
SCHEMBL10191613 0.86 ALDH1A1 (0.61) FFAR1ALDH1A1CYP1A2HPGDKDM4E
SCHEMBL3914823 0.83 NPC1 (0.59) ALDH1A1CYP1A2HPGDRAB9ANPC1
SCHEMBL12700436 0.83 HTT (0.53) ALDH1A1CYP1A2HPGDRAB9AKMT2A
SCHEMBL3757836 0.83 KMT2A (0.69) FFAR1ALDH1A1CYP1A2HPGDKDM4E
SCHEMBL9158022 0.82 MEN1 (0.62) FFAR1ALDH1A1CYP1A2HPGDKDM4E
SCHEMBL9157758 0.82 MEN1 (0.62) FFAR1ALDH1A1CYP1A2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9622991-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2017-04-18 — — US disclosed
US-9144557-B2 Hematopoietic growth factor mimetic small molecule compounds and their uses LIGAND PHARMACEUTICALS INC. (US) 2015-09-29 — — US disclosed
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2015-09-10 — — US disclosed
US-20140243324-A1 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2014-08-28 — — US disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 — — WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243324-A1 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS HGF, EPOR, MPL FFAR1 4331/4885ALDH1A1 3228/4885CYP1A2 4797/4885
US-20150252043-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES MPL, CSF3R, HGF FFAR1 1776/4885ALDH1A1 2736/4885CYP1A2 4846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback